NCT06577493

Effectiveness of Phenazopyridine for Pain Following Urodynamics

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 66 (estimated)
• Sponsor: University of South Florida · Academic / Other
• Sex: Female
• Age: 18 Years – 99 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.

Conditions

• Pain After Urodynamic Testing

Interventions

Type	Name	Description
DRUG	Phenazopyridine Hydrochloride 99.5 MG	Experimental arm to take two 99.5 mg phenazopyridine hydrochloride by mouth for a total of 199mg immediately prior to start of urodynamic testing

Timeline

• Start date: 2024-12-17
• Primary completion: 2025-07-01
• Completion: 2025-07-01
• First posted: 2024-08-29
• Last updated: 2025-04-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study